#1 Startup Dataset
Growth rates, revenue data, direct competitors and contact details.
Thomas Capozza Email
VP, Clinical Development . Intercept Pharmaceuticals
New York, NY
Locationt*************@interceptpharma.com
Primary EmailHow to contact Thomas Capozza
Join and see Thomas's contact info for free!Current Roles
Employees:
461Revenue:
$354.3MAbout
New York City-based Intercept Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company focused on developing small molecule drugs for the treatment of chronic liver and metabolic diseases. Since 2002, Intercept researchers have published extensively on the key role of the farnesoid X receptor (FXR) as a regulator of bile and cholesterol metabolism in the liver with preclinical data from numerous studies providing strong rationale for the advancement of FXR agonists as hepatoprotective therapeutics in chronic liver disease. The company intends to lead in the advancement of drug candidates acting on FXR and other bile acid receptors and is developing a pipeline of novel lead compounds for multiple indications.Intercept Pharmaceuticals Address
10 Hudson YardsNew York, NY
United States